home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

107 rows where docket_id = "FDA-2007-D-0369" and posted_year = 2022 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_end_date, last_modified, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 2

  • Other 101
  • Notice 6

posted_year 1

  • 2022 · 107 ✖

agency_id 1

  • FDA 107
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0743 FDA None FDA-2007-D-0369 Request for Extension from King & Spalding Other Request for Extension 2022-12-13T05:00:00Z 2022 12 2022-12-13T05:00:00Z   2022-12-13T19:02:41Z   0 0 090000648553435b
FDA-2007-D-0369-0699 FDA None FDA-2007-D-0369 PSG_019726 - Draft Guidance on Goserelin acetate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:16Z   1 0 09000064854d1eb8
FDA-2007-D-0369-0698 FDA None FDA-2007-D-0369 PSG_019488 - Draft Guidance on Nicardipine Hydrochloride Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:16Z   1 0 09000064854d1eb6
FDA-2007-D-0369-0711 FDA None FDA-2007-D-0369 PSG_021526 - Draft Guidance on Ranolazine Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:28Z   1 0 09000064854d2041
FDA-2007-D-0369-0721 FDA None FDA-2007-D-0369 PSG_207962 - Draft Guidance on Lidocaine Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:31Z   1 0 09000064854d2065
FDA-2007-D-0369-0718 FDA None FDA-2007-D-0369 PSG_203791 - Draft Guidance on Acyclovir Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:29Z   1 0 09000064854d2051
FDA-2007-D-0369-0726 FDA None FDA-2007-D-0369 PSG_211172 - Draft Guidance on Inotersen Sodium Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:33Z   1 0 09000064854d207f
FDA-2007-D-0369-0704 FDA None FDA-2007-D-0369 PSG_020701 - Draft Guidance on Progesterone Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:17Z   1 0 09000064854d1f74
FDA-2007-D-0369-0700 FDA None FDA-2007-D-0369 PSG_020080-Autoinj - Draft Guidance on Sumatriptan Succinate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:17Z   1 0 09000064854d1eba
FDA-2007-D-0369-0732 FDA None FDA-2007-D-0369 PSG_213716 - Draft Guidance on Voclosporin Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:31Z   1 0 09000064854d206b
FDA-2007-D-0369-0710 FDA None FDA-2007-D-0369 PSG_021361 - Draft Guidance on Rifaximin Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:29Z   1 0 09000064854d2055
FDA-2007-D-0369-0722 FDA None FDA-2007-D-0369 PSG_208090 - Draft Guidance on Oxycodone Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:30Z   1 0 09000064854d205d
FDA-2007-D-0369-0737 FDA None FDA-2007-D-0369 PSG_214200 - Draft Guidance on Trilaciclib Dihydrochloride Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:32Z   1 0 09000064854d2079
FDA-2007-D-0369-0723 FDA None FDA-2007-D-0369 PSG_208843 - Draft Guidance on Hydroxyurea Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:29Z   1 0 09000064854d204f
FDA-2007-D-0369-0740 FDA None FDA-2007-D-0369 PSG_215712 - Draft Guidance on Mometasone Furoate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:30Z   1 0 09000064854d2063
FDA-2007-D-0369-0709 FDA None FDA-2007-D-0369 PSG_021066 - Draft Guidance on Ketotifen fumarate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:28Z   1 0 09000064854d203b
FDA-2007-D-0369-0729 FDA None FDA-2007-D-0369 PSG_213135 - Draft Guidance on Magnesium Sulfate; Potassium Chloride; Sodium Sulfate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:29Z   1 0 09000064854d2057
FDA-2007-D-0369-0742 FDA None FDA-2007-D-0369 PSG_216018 - Draft Guidance on Ranolazine Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:30Z   1 0 09000064854d205b
FDA-2007-D-0369-0739 FDA None FDA-2007-D-0369 PSG_215650 - Draft Guidance on Clindamycin Phosphate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:31Z   1 0 09000064854d206f
FDA-2007-D-0369-0716 FDA None FDA-2007-D-0369 PSG_078878 - Draft Guidance on Omeprazole Magnesium Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:33Z   1 0 09000064854d2081
FDA-2007-D-0369-0714 FDA None FDA-2007-D-0369 PSG_022059 - Draft Guidance on Lapatinib Ditosylate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:28Z   1 0 09000064854d203f
FDA-2007-D-0369-0717 FDA None FDA-2007-D-0369 PSG_202057 - Draft Guidance on Icosapent Ethyl Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:29Z   1 0 09000064854d2059
FDA-2007-D-0369-0728 FDA None FDA-2007-D-0369 PSG_212904 - Draft Guidance on Tivozanib Hydrochloride Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:32Z   1 0 09000064854d207d
FDA-2007-D-0369-0702 FDA None FDA-2007-D-0369 PSG_020508 - Draft Guidance on Ammonium Lactate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:08Z   1 0 09000064854d2699
FDA-2007-D-0369-0712 FDA None FDA-2007-D-0369 PSG_021825 - Draft Guidance on Deferiprone Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:27Z   1 0 09000064854d0dd6
FDA-2007-D-0369-0731 FDA None FDA-2007-D-0369 PSG_213498 - Draft Guidance on Ponesimod Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:28Z   1 0 09000064854d2043
FDA-2007-D-0369-0735 FDA None FDA-2007-D-0369 PSG_214096 - Draft Guidance on Tepotinib Hydrochloride Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:30Z   1 0 09000064854d2061
FDA-2007-D-0369-0695 FDA None FDA-2007-D-0369 PSG_017441 - Draft Guidance on Ferric Oxyhydroxide Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:16Z   1 0 09000064854d1d1a
FDA-2007-D-0369-0741 FDA None FDA-2007-D-0369 PSG_215935 - Draft Guidance on Budesonide Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:32Z   1 0 09000064854d2073
FDA-2007-D-0369-0724 FDA None FDA-2007-D-0369 PSG_208845 - Draft Guidance on Triamcinolone Acetonide Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:32Z   1 0 09000064854d207b
FDA-2007-D-0369-0705 FDA None FDA-2007-D-0369 PSG_020955 - Draft Guidance on Ferric Oxyhydroxide Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:08Z   1 0 09000064854d269e
FDA-2007-D-0369-0727 FDA None FDA-2007-D-0369 PSG_212269 - Draft Guidance on Deferiprone Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:30Z   1 0 09000064854d205f
FDA-2007-D-0369-0701 FDA None FDA-2007-D-0369 PSG_020080-Vial - Draft Guidance on Sumatriptan Succinate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:17Z   1 0 09000064854d1ebc
FDA-2007-D-0369-0703 FDA None FDA-2007-D-0369 PSG_020578 - Draft Guidance on Goserelin acetate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:17Z   1 0 09000064854d1f72
FDA-2007-D-0369-0693 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z   2023-02-17T15:36:29Z 2022-25210 0 0 09000064854d0520
FDA-2007-D-0369-0713 FDA None FDA-2007-D-0369 PSG_021892 - Draft Guidance on Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:28Z   1 0 09000064854d203d
FDA-2007-D-0369-0719 FDA None FDA-2007-D-0369 PSG_206488 - Draft Guidance on Eteplirsen Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:31Z   1 0 09000064854d2067
FDA-2007-D-0369-0734 FDA None FDA-2007-D-0369 PSG_214018 - Draft Guidance on Fosdenopterin Hydrobromide Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:31Z   1 0 09000064854d2069
FDA-2007-D-0369-0725 FDA None FDA-2007-D-0369 PSG_210922 - Draft Guidance on Patisiran Sodium Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:29Z   1 0 09000064854d2053
FDA-2007-D-0369-0736 FDA None FDA-2007-D-0369 PSG_214154 - Draft Guidance on Drospirenone; Estetrol Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:32Z   1 0 09000064854d2077
FDA-2007-D-0369-0696 FDA None FDA-2007-D-0369 PSG_017769 - Draft Guidance on Calcitonin Salmon Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:16Z   1 0 09000064854d1d1c
FDA-2007-D-0369-0706 FDA None FDA-2007-D-0369 PSG_020958 - Draft Guidance on Calcium Carbonate; Famotidine; Magnesium Hydroxide Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:17Z   1 0 09000064854d1f7a
FDA-2007-D-0369-0707 FDA None FDA-2007-D-0369 PSG_021026 - Draft Guidance on Miconazole Nitrate; White Petrolatum; Zinc Oxide Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-07T00:43:17Z   1 0 09000064854d1fed
FDA-2007-D-0369-0715 FDA None FDA-2007-D-0369 PSG_050704 - Draft Guidance on Daunorubicin Citrate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:28Z   1 0 09000064854d0dd8
FDA-2007-D-0369-0697 FDA None FDA-2007-D-0369 PSG_019155 - Draft Guidance on Ammonium Lactate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:08Z   1 0 09000064854d2544
FDA-2007-D-0369-0708 FDA None FDA-2007-D-0369 PSG_021065 - Draft Guidance on Ethinyl Estradiol; Norethindrone Acetate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:27Z   1 0 09000064854d0dd4
FDA-2007-D-0369-0738 FDA None FDA-2007-D-0369 PSG_214383 - Draft Guidance on Melphalan Flufenamide Hydrochloride Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:31Z   1 0 09000064854d2071
FDA-2007-D-0369-0720 FDA None FDA-2007-D-0369 PSG_207924 - Draft Guidance on Baricitinib Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:33Z   1 0 09000064854d2083
FDA-2007-D-0369-0730 FDA None FDA-2007-D-0369 PSG_213138 - Draft Guidance on Fidaxomicin Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:31Z   1 0 09000064854d206d
FDA-2007-D-0369-0733 FDA None FDA-2007-D-0369 PSG_213978 - Draft Guidance on Varenicline Tartrate Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:32Z   1 0 09000064854d2075
FDA-2007-D-0369-0694 FDA None FDA-2007-D-0369 PSG_016199 - Draft Guidance on Hydrocortisone Other Guidance 2022-11-18T05:00:00Z 2022 11 2022-11-18T05:00:00Z 2023-04-19T03:59:59Z 2024-11-12T23:47:08Z   1 0 09000064854d2540
FDA-2007-D-0369-0692 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2022-10-24T04:00:00Z 2022 10 2022-10-24T04:00:00Z   2022-10-24T17:57:15Z 2022-23015 0 0 090000648544cb99
FDA-2007-D-0369-0660 FDA None FDA-2007-D-0369 Draft Guidance on Technetium Tc-99m Sodium Pertechnetate Generator- PSG_202158 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:20Z   1 0 090000648520a044
FDA-2007-D-0369-0664 FDA None FDA-2007-D-0369 Draft Guidance on Cobicistat; Darunavir; Emtricitabine; Tenofovir Alafenamide Fumarate - PSG_210455 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:20Z   1 0 090000648520a04c
FDA-2007-D-0369-0670 FDA None FDA-2007-D-0369 Draft Guidance on Acetaminophen; Ibuprofen - PSG_211733 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:21Z   1 0 090000648520a058
FDA-2007-D-0369-0673 FDA None FDA-2007-D-0369 Draft Guidance on Cabotegravir Sodium - PSG_212887 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:22Z   1 0 090000648520a05e
FDA-2007-D-0369-0637 FDA None FDA-2007-D-0369 Draft Guidance on Ketoprofen - PSG_018754 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:16Z   1 0 09000064852092e0
FDA-2007-D-0369-0652 FDA None FDA-2007-D-0369 Draft Guidance on Olopatadine Hydrochloride - PSG_021861 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:19Z   1 0 090000648520a01b
FDA-2007-D-0369-0658 FDA None FDA-2007-D-0369 Draft Guidance on Dantrolene Sodium - PSG_205579 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:19Z   1 0 090000648520a027
FDA-2007-D-0369-0666 FDA None FDA-2007-D-0369 Draft Guidance on Cytarabine; Daunorubicin - PSG_209401 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:21Z   1 0 090000648520a050
FDA-2007-D-0369-0643 FDA None FDA-2007-D-0369 Draft Guidance on Lamotrigine - PSG_020764 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:17Z   1 0 090000648520a009
FDA-2007-D-0369-0681 FDA None FDA-2007-D-0369 Draft Guidance on Dasiglucagon Hydrochloride - PSG_214231 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:23Z   1 0 090000648520a08d
FDA-2007-D-0369-0649 FDA None FDA-2007-D-0369 Draft Guidance on Lanthanum Carbonate - PSG_021468 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:18Z   1 0 090000648520a015
FDA-2007-D-0369-0654 FDA None FDA-2007-D-0369 Draft Guidance on Amoxicillin; Clavulanate Potassium - PSG_050726 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:19Z   1 0 090000648520a01f
FDA-2007-D-0369-0674 FDA None FDA-2007-D-0369 Draft Guidance on Vibegron - PSG_213006 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:22Z   1 0 090000648520a07f
FDA-2007-D-0369-0680 FDA None FDA-2007-D-0369 Draft Guidance on Azelastine Hydrochloride - PSG_213872 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:23Z   1 0 090000648520a08b
FDA-2007-D-0369-0684 FDA None FDA-2007-D-0369 Draft Guidance on Cyclosporine - PSG_214965 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:23Z   1 0 090000648520a093
FDA-2007-D-0369-0640 FDA None FDA-2007-D-0369 Draft Guidance on Medroxyprogesterone Acetate - PSG_012541 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:16Z   1 0 090000648520a003
FDA-2007-D-0369-0663 FDA None FDA-2007-D-0369 Draft Guidance on Meloxicam - PSG_210583 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:20Z   1 0 090000648520a04a
FDA-2007-D-0369-0644 FDA None FDA-2007-D-0369 Draft Guidance on Famotidine - PSG_020801 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:17Z   1 0 090000648520a00b
FDA-2007-D-0369-0651 FDA None FDA-2007-D-0369 Draft Guidance on Cetirizine Hydrochloride - PSG_021621 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:18Z   1 0 090000648520a019
FDA-2007-D-0369-0657 FDA None FDA-2007-D-0369 Draft Guidance on Ampicillin/Ampicillin Trihydrate - PSG_064082 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:19Z   1 0 090000648520a025
FDA-2007-D-0369-0656 FDA None FDA-2007-D-0369 Draft Guidance on Ethinyl Estradiol; Norethindrone Acetate - PSG_203667 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:19Z   1 0 090000648520a023
FDA-2007-D-0369-0662 FDA None FDA-2007-D-0369 Draft Guidance on Tacrolimus - PSG_210115 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:20Z   1 0 090000648520a048
FDA-2007-D-0369-0672 FDA None FDA-2007-D-0369 Draft Guidance on Nifurtimox - PSG_213464 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:21Z   1 0 090000648520a05c
FDA-2007-D-0369-0676 FDA None FDA-2007-D-0369 Draft Guidance on Vericiguat - PSG_214377 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:22Z   1 0 090000648520a083
FDA-2007-D-0369-0668 FDA None FDA-2007-D-0369 Draft Guidance on Upadacitinib - PSG_211675 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:21Z   1 0 090000648520a054
FDA-2007-D-0369-0669 FDA None FDA-2007-D-0369 Draft Guidance on Loteprednol Etabonate - PSG_210933 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:21Z   1 0 090000648520a056
FDA-2007-D-0369-0677 FDA None FDA-2007-D-0369 Draft Guidance on Setmelanotide Acetate - PSG_213793 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:22Z   1 0 090000648520a085
FDA-2007-D-0369-0682 FDA None FDA-2007-D-0369 Draft Guidance on Relugolix - PSG_214621 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:23Z   1 0 090000648520a08f
FDA-2007-D-0369-0638 FDA None FDA-2007-D-0369 Draft Guidance on Ibuprofen - PSG_020601 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:16Z   1 0 09000064852092e2
FDA-2007-D-0369-0648 FDA None FDA-2007-D-0369 Draft Guidance on Methylphenidate Hydrochloride - PSG_021475 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:18Z   1 0 090000648520a013
FDA-2007-D-0369-0665 FDA None FDA-2007-D-0369 Draft Guidance on Oxymetazoline Hydrochloride; Tetracaine Hydrochloride - PSG_208032 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:20Z   1 0 090000648520a04e
FDA-2007-D-0369-0679 FDA None FDA-2007-D-0369 Draft Guidance on Lonafarnib - PSG_213969 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:23Z   1 0 090000648520a089
FDA-2007-D-0369-0659 FDA None FDA-2007-D-0369 Draft Guidance on Prednisone - PSG_202020 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:20Z   1 0 090000648520a042
FDA-2007-D-0369-0671 FDA None FDA-2007-D-0369 Draft Guidance on Gallium Ga-68 Gozetotide - PSG_212642 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:21Z   1 0 090000648520a05a
FDA-2007-D-0369-0639 FDA None FDA-2007-D-0369 Draft Guidance on Medroxyprogesterone Acetate - PSG_020246 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:16Z   1 0 090000648520a001
FDA-2007-D-0369-0641 FDA None FDA-2007-D-0369 Draft Guidance on Carbamazepine - PSG_018281 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:17Z   1 0 090000648520a005
FDA-2007-D-0369-0642 FDA None FDA-2007-D-0369 Draft Guidance on Loperamide Hydrochloride; Simethicone - PSG_020606 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:17Z   1 0 090000648520a007
FDA-2007-D-0369-0653 FDA None FDA-2007-D-0369 Draft Guidance on Etonogestrel - PSG_021529 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:19Z   1 0 090000648520a01d
FDA-2007-D-0369-0667 FDA None FDA-2007-D-0369 Draft Guidance on Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate - PSG_210526 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:21Z   1 0 090000648520a052
FDA-2007-D-0369-0678 FDA None FDA-2007-D-0369 Draft Guidance on Berotralstat Hydrochloride - PSG_214094 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:22Z   1 0 090000648520a087
FDA-2007-D-0369-0683 FDA None FDA-2007-D-0369 Draft Guidance on Pafolacianine Sodium - PSG_214907 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:23Z   1 0 090000648520a091
FDA-2007-D-0369-0655 FDA None FDA-2007-D-0369 Draft Guidance on Loratadine - PSG_021891 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:19Z   1 0 090000648520a021
FDA-2007-D-0369-0645 FDA None FDA-2007-D-0369 Draft Guidance on Caspofungin Acetate - PSG_021227 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:17Z   1 0 090000648520a00d
FDA-2007-D-0369-0647 FDA None FDA-2007-D-0369 Draft Guidance on Caspofungin Acetate - PSG_021227 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:17Z   1 0 090000648520a011
FDA-2007-D-0369-0661 FDA None FDA-2007-D-0369 Draft Guidance on Doxycycline Hyclate - PSG_050751 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:20Z   1 0 090000648520a046
FDA-2007-D-0369-0636 FDA None FDA-2007-D-0369 Draft Guidance on Azelastine Hydrochloride - PSG_020114 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:16Z   1 0 09000064852092de
FDA-2007-D-0369-0646 FDA None FDA-2007-D-0369 Draft Guidance on Nicotine - PSG_020385 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:17Z   1 0 090000648520a00f
FDA-2007-D-0369-0675 FDA None FDA-2007-D-0369 Draft Guidance on Mometasone Furoate; Olopatadine Hydrochloride - PSG_211746 Other Guidance 2022-08-05T04:00:00Z 2022 8 2022-08-05T04:00:00Z 2022-10-04T03:59:59Z 2024-11-07T00:41:22Z   1 0 090000648520a081

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 1182.925ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API